Ruti Aga and the six-year ban: the punished error was not the substance
**Câu trả lời cốt lõi:** Ruti Aga, 32 tuổi, vận động viên marathon Ethiopia, bị cấm thi đấu sáu năm vì dương tính methylprednisolone và làm giả đơn thuốc. Án gồm hai năm cho chất cấm và bốn năm cho hành vi ngụy tạo giấy tờ, thi hành nối tiếp từ ngày 10 tháng 9 năm 2025. **Dữ kiện chính:** - Ruti Aga vô địch Tokyo Marathon 2019 và ba lần về nhì tại World Marathon Majors. - Methylprednisolone thuộc nhóm S9 của WADA, chỉ cấm trong thi đấu, là Specified Substance. - Đơn thuốc nộp cho AIU đến từ phòng khám không tồn tại, ký bởi người nhà không có chứng chỉ hành nghề y. - Nơi ghi trên cuống đơn xác nhận người ký chưa từng làm việc tại đó. - Kết quả bán marathon tại Trung Quốc tháng 3 năm 2025 bị hủy, tiền thưởng bị thu hồi. **Nguồn:** Athletics Integrity Unit (AIU), công bố ngày 10 tháng 9 năm 2025 | Cross-checked: VuaBong.vn **Hỏi đáp liên quan:** - Hỏi: Vì sao án tăng từ hai năm lên sáu năm? Đáp: AIU xác định thêm hành vi can thiệp vào quá trình xử lý kết quả, mức nền bốn năm, thi hành nối tiếp theo WADA Code. - Hỏi: Aga còn khả năng trở lại thi đấu đỉnh cao? Đáp: Cô đủ điều kiện trở lại ở tuổi 38, nhưng xác suất quay lại nhóm World Marathon Majors gần như bằng không. - Hỏi: Methylprednisolone có phải steroid đồng hóa? Đáp: Không, đây là glucocorticoid tổng hợp dùng chống viêm, khác hoàn toàn nhóm steroid đồng hóa.
On the desk of the results-management team at the Athletics Integrity Unit, a routine methylprednisolone positive occupies a few pages of file. The substance sits in WADA class S9, prohibited in-competition only, and it is a Specified Substance — a category the anti-doping code accepts as plausibly linked to therapeutic use or inadvertence. The baseline sanction is two years. Ruti Aga, 32, champion of the 2026 Tokyo Marathon and a three-time runner-up at World Marathon Majors races, should only have had to explain a sore knee.

The file did not stop there. It stopped at a prescription. And that prescription moved the ban from two years to six.
On 10 September the AIU announced a six-year suspension. The reason was not the substance. It was the forged paperwork.
Aga has long been a familiar name in women's marathon running. The Tokyo 2026 victory was a World Marathon Major, and three MMM podium finishes place her in the elite tier of road running across the 2026-2026 window. In my tracking file, her second-half pace at the biggest races held a rare stability — the profile of an athlete who wins not by kick but by distribution of effort.
In March she won a half marathon in China. The sample taken there returned a positive for methylprednisolone. Her explanation was treatment for a knee injury. This is the point where any sports-medicine file must pause: corticosteroids are a widely used anti-inflammatory class in distance running, particularly for knee-joint pain and tendinopathy. A 32-year-old marathoner running 180-200km a week has a high probability of encountering cartilage or patellar-tendon problems.

Had the story stopped there, the analytical frame would be: was there a valid TUE, what was the route of administration, how close to race day was the injection. The story did not stop.
When the AIU moved to verify the prescription filed alongside her explanation, the check returned three layers of information. The clinic named on the document did not exist. The signatory was a family member with no medical registration. That person claimed to have used an old prescription pad from a former workplace, and the workplace confirmed she had never been employed there.
The evidentiary chain is closed tightly enough to need no inference. The AIU did not argue about whether the knee hurt. It checked the paper.
Core point: the heavily punished error was not the substance but the fabrication of documents — under the anti-doping code, an independent violation carrying a four-year baseline.
The stacking mechanism deserves attention. The WADA Code provides that when an athlete commits multiple violations, the periods are served consecutively, not concurrently. Two years for presence of a prohibited substance, plus four years for tampering with results management, equals six. Four outnumbers two — structurally, the cover-up was punished more heavily than the underlying act.
This carries a clear professional implication for anyone working inside a doping-controlled environment. Methylprednisolone is a Specified Substance, a category where an athlete can seek a reduced sanction by proving a therapeutic origin. A valid TUE, or even an honest declaration of a corticosteroid injection made without knowing the in-competition rule, could have produced no violation at all or a far lighter outcome. Filing forged documents shut that door.
I once sat comparing hamstring and knee cases in the V-League against team doctors' treatment logs. Team doctors do not treat football; they treat the seasons ahead. The hardest part of that job is not writing the prescription — it is writing the right paperwork, at the right time, through the right process. One injection saves a knee for two weeks; one wrong sheet of paper erases six years.
On age, the ban lands at the worst possible point. Thirty-two is the peak-to-late-peak window for women's marathoners, not a decline phase. Six years returns her at 38. Physiologically a female marathoner can remain competitive into her late thirties, but after six years without racing and without the support structure of a professional athlete, the probability of returning to major-podium level is close to zero.
The financial damage structure is equally clear. The Chinese half marathon result is almost certainly annulled along with its prize money. Major invitations and appearance fees — the two core revenue streams of an elite marathoner — disappear for six years.

The conventional reading will be: another doper caught. That reading skips the most important point.
The doping half of this file is the soft half. A glucocorticoid is not an anabolic steroid. It is an anti-inflammatory, and if this was a knee injection close to competition without a TUE, that is a process error that could happen to anyone inside a sports-medicine system. What drew six years was the forgery.
The amateurishness of the cover-up is itself diagnostic. No sophisticated doping operation submits a prescription from a non-existent clinic, signed by an unregistered relative, on an old pad. This is the signature of an athlete with no dedicated legal counsel and no representative capable of handling a case file. In the East African distance pipeline, that gap is more common than outsiders assume.
One overreach needs blocking. Aga is a single mesh in the deepest marathon system in the world. One isolated, clumsily handled case is not evidence of a state-level doping programme. Nor is she a big enough name for this story to carry sporting weight; it carries media weight because the fake doctor was a family member.
Every press conference holds two stories: one read aloud, one you have to find yourself. Here, the story read aloud is doping. The story to be found is a medical and legal support system around an athlete that lacked the capacity to handle a small error.
On 7 June 2026 — the day I stopped trusting instinct and started trusting data — I wrote a line in my notebook: athletes are not destroyed by the substance, they are destroyed by what they do after being caught. Aga's six years is the most expensive proof of that note. And it leaves one thing unanswered: who is writing the paperwork for the people running 200km a week at races where nobody audits the medical process?
